Matthew Perrone
Dayton Daily News
Washington, DC, United States
Contact Matthew
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Matthew:
FDA pick parries questions at collegial confirmation hearing
WASHINGTON (AP) — President Joe Biden’s pick to lead the Food and Drug Administration parried questions on crises ranging from the COVID-19 pandemic to the opioid epidemic, during a collegial Senate hearing Tuesday that seemed to bode well for his confirmation. → Read More
Pfizer confirms COVID pill's results, potency versus omicron
WASHINGTON (AP) — Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. → Read More
FDA expands Pfizer COVID booster, opens extra dose to age 16
The U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer’s vaccine. → Read More
US OKs new COVID-19 antibody drug for high-risk patients
WASHINGTON (AP) — Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination. → Read More
FDA panel backs first-of-a-kind COVID-19 pill from Merck
WASHINGTON (AP) — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. → Read More
FDA: Merck COVID pill effective, experts will review safety
Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy. → Read More
New hurdle for COVID-19 home testing
WASHINGTON (AP) — Millions more home tests for COVID-19 are hitting store shelves, but will there be enough for Americans hoping to screen themselves before holiday gatherings? → Read More
FDA official explains decision on 'simplified' booster shots
WASHINGTON (AP) — The U.S. government's booster campaign got a lot simpler Friday after Food and Drug Administration officials authorized extra shots of Pfizer and Moderna COVID-19 vaccines for all adults. → Read More
US advisers support expanding COVID boosters to all adults
WASHINGTON (AP) — The U.S. government on Friday moved to open up COVID-19 booster shots to all adults, expanding efforts to get ahead of rising coronavirus cases that experts fear could snowball into a winter surge as millions of Americans travel for the holidays. → Read More
US opens COVID boosters to all adults, urges them for 50+
WASHINGTON (AP) — The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise even before millions of Americans travel for the holidays. → Read More
US opens COVID boosters to all adults, urges them for 50+
WASHINGTON (AP) — The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise even before millions of Americans travel for the holidays. → Read More
US expands COVID boosters to all adults, final hurdle ahead
WASHINGTON (AP) — U.S. regulators on Friday opened up COVID-19 booster shots to all adults, expanding the government’s campaign to shore up protection and get ahead of rising coronavirus cases that may worsen with the holidays. → Read More
Pfizer says COVID-19 pill cut hospital, death risk by 90%
WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. → Read More
UK authorizes Merck's COVID pill, 1st shown to treat COVID
Initial supplies will be limited. Merck has said it can produce 10 million treatment courses through the end of the year, but much of that supply has already been purchased by governments worldwide. In October, U.K. officials announced they secured 480,000 courses of molnupiravir and expected thousands of vulnerable Britons to have access to the treatment this winter via a national study. “Today… → Read More
UK authorizes Merck antiviral pill, 1st shown to treat COVID
LONDON (AP) — Britain has granted a conditional authorization to Merck's coronavirus antiviral, the first pill shown to successfully treat COVID-19. It is the first country to OK the treatment, although it was not immediately clear how quickly the pill would be available. → Read More
FDA paves way for Pfizer COVID-19 vaccinations in young kids
WASHINGTON (AP) — The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer's COVID-19 vaccine. → Read More
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters
WASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially. → Read More
US regulators lay out plan for over-the-counter hearing aids
WASHINGTON (AP) — Health regulators on Tuesday unveiled their proposal to allow Americans to buy hearing aids without a prescription, a long-awaited move intended to make the devices more accessible to millions of people with hearing problems. → Read More
FDA panel endorses booster shot for J&J COVID-19 vaccine
WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing growing worry that Americans who got the single-dose shot aren’t as protected as those given two-dose brands. → Read More
FDA authorizes first e-cigarettes, cites benefit for smokers
WASHINGTON (AP) — Heath officials on Tuesday authorized the first electronic cigarettes in the U.S., saying the R.J. Reynolds vaping products can benefit adult smokers. → Read More